Floatz logo

ds-6051b

Advanced Solid Malignant Tumors

Daiichi Sankyo Co., Ltd.Phase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Advanced Solid Malignant Tumors cohort.

Asset / SponsorPhaseRating
u3-1565
Daiichi Sankyo
Phase 1CC
ds-1123
Daiichi Sankyo Co., Ltd.
Phase 1CC
ds-5573a
Daiichi Sankyo Co., Ltd.
Phase 1CC

Same molecule, other indications

ds-6051b is also rated in:

non-small cell lung carcinomaDormant
B
Indicative ·
56 / 100
View asset →
neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →
NeoplasmsDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →